Skip to main content
. Author manuscript; available in PMC: 2015 Jan 21.
Published in final edited form as: J Neurosci Res. 2010 Nov 1;88(14):3090–3101. doi: 10.1002/jnr.22458

Fig. 4.

Fig. 4

STAT1 and PI3K inhibitors did not alter HBMEC viability. AlamarBlue assay show that 24-hr exposure of HBMEC to the STAT1 inhibitor fludarabine (FLUD; 1–100 μM; A) or the PI3K inhibitor LY-294002 (1–50 μM; B) did not induce cytotoxicity. Control represents untreated cells. HBMEC treated with methanol (50%) and saponin (0.1%) were used as positive control (★★★P < 0.001).